Growth Metrics

Lifecore Biomedical (LFCR) Long-Term Deferred Tax: 2015-2018

Historic Long-Term Deferred Tax for Lifecore Biomedical (LFCR) over the last 4 years, with May 2018 value amounting to $17.5 million.

  • Lifecore Biomedical's Long-Term Deferred Tax fell 28.87% to $17.5 million in Q2 2018 from the same period last year, while for May 2018 it was $17.5 million, marking a year-over-year decrease of 28.87%. This contributed to the annual value of $17.5 million for FY2018, which is 28.87% down from last year.
  • Per Lifecore Biomedical's latest filing, its Long-Term Deferred Tax stood at $17.5 million for FY2018, which was down 28.87% from $24.6 million recorded in FY2017.
  • In the past 5 years, Lifecore Biomedical's Long-Term Deferred Tax registered a high of $32.2 million during FY2015, and its lowest value of $17.5 million during FY2018.
  • For the 3-year period, Lifecore Biomedical's Long-Term Deferred Tax averaged around $21.5 million, with its median value being $22.4 million (2016).
  • Its Long-Term Deferred Tax has fluctuated over the past 5 years, first plummeted by 30.37% in 2016, then rose by 9.53% in 2017.
  • Yearly analysis of 4 years shows Lifecore Biomedical's Long-Term Deferred Tax stood at $32.2 million in 2015, then slumped by 30.37% to $22.4 million in 2016, then increased by 9.53% to $24.6 million in 2017, then declined by 28.87% to $17.5 million in 2018.